ALERT!

This site is not optimized for Internet Explorer 8 (or older).

Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.

Thoracic

October 30, 2019
A balanced  appraisal of last year's manuscript from the Lancet Group on a relatively novel portable Organ Care System for donor lungs. The analysis of the technical complications, especially organ damage from overenthusiastic revving of the pump, is particularly sobering.
October 25, 2019
A Thoracic Surgery Foundation International Medical Volunteer describes her experience in Pokhara, Nepal, as a new surgeon volunteer treating underserved patients.
October 25, 2019
Persistent opioid use (>90 days postoperatively) in this Medicare database study identified modifiable factors, including prescription size and preoperative prescription refills, among other features, that could be targeted in order to reduce opioid dependency.
October 24, 2019
In this Giants of Cardiothoracic Surgery interview, Marco Nardini speaks with Franca Melfi of the University of Pisa in Italy about her experience with robotic thoracic surgery technology.
October 24, 2019
Identification of Anonymous MRI Research Participants with Face-Recognition Software:  The authors demonstrated the ability to use facial recognition software to identify individuals undergoing head MR, highlighting the risk of loss of anonymity when seemingly de-identified data are available to others.
October 24, 2019
The National Cancer Database was queried regarding esophageal squamous cancer cases from 2004-2013, and over 11,000 patients were identified. Definitive chemoradiotherapy was used in 79%, whereas resection was employed in 21% at some phase of therapy.
October 24, 2019
This multiinstitutional study including advocates of robotic lung resection identified a 1.9% incidence of intraoperative castrophes, most commonly pulmonary arterial bleeding. Patients at risk had lower FEV1%, higher clinical stage, and more frequent preoperative radiation therapy.
October 24, 2019
This analysis of data from the JCOG0201 trial identified factors that place patients at increased risk for recurrence after lobectomy for stage I adenocarcinoma. They include visceral pleural invasion, vascular invasion, or an invasive component measuring >2 cm.
October 21, 2019
Keith S. Naunheim of St Louis University in Missouri, USA, presents a discussion on surgery for stage IIIA non-small cell lung cancer.

Pages